Variant report

Variant	esv3371480
Chromosome Location	chr2:113189306-113191854
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:113191140-113191422	HepG2	liver:	n/a	n/a
2	BATF	chr2:113190902-113191359	GM12878	blood:	n/a	n/a
3	BCL11A	chr2:113190924-113191364	GM12878	blood:	n/a	n/a
4	BCL11A	chr2:113189890-113190179	GM12878	blood:	n/a	n/a
5	BCL11A	chr2:113190977-113191179	GM12878	blood:	n/a	n/a
6	BHLHE40	chr2:113191038-113191377	HepG2	liver:	n/a	n/a
7	BHLHE40	chr2:113191140-113191340	GM12878	blood:	n/a	n/a
8	CBX3	chr2:113191037-113191412	K562	blood:	n/a	n/a
9	CTCF	chr2:113191200-113191350	A549	lung:	n/a	chr2:113191269-113191282
10	CTCF	chr2:113189503-113189686	IMR90	lung:	n/a	n/a
11	CTCF	chr2:113191240-113191390	MCF-7	breast:	n/a	chr2:113191269-113191282
12	CTCF	chr2:113191155-113191346	MCF-7	breast:	n/a	chr2:113191269-113191282
13	CTCF	chr2:113190370-113190538	GM10266	blood:	n/a	n/a
14	CTCF	chr2:113191220-113191370	GM12865	blood:	n/a	chr2:113191269-113191282
15	CTCF	chr2:113191121-113191350	HepG2	liver:	n/a	chr2:113191269-113191282
16	CTCF	chr2:113191002-113191436	Lung_OC	lung:	n/a	chr2:113191269-113191282
17	CTCF	chr2:113191220-113191370	HMF	breast:	n/a	chr2:113191269-113191282
18	CTCF	chr2:113191200-113191350	SK-N-SH_RA	brain:	n/a	chr2:113191269-113191282
19	CTCF	chr2:113191220-113191370	AoAF	blood vessel:	n/a	chr2:113191269-113191282
20	CTCF	chr2:113191220-113191370	GM12873	blood:	n/a	chr2:113191269-113191282
21	CTCF	chr2:113191220-113191370	GM12864	blood:	n/a	chr2:113191269-113191282
22	CTCF	chr2:113190320-113190470	AG04449	skin:	n/a	n/a
23	CTCF	chr2:113189620-113189770	HBMEC	blood vessel:	n/a	n/a
24	CTCF	chr2:113191200-113191350	AG04450	lung:	n/a	chr2:113191269-113191282
25	CTCF	chr2:113189520-113189670	AoAF	blood vessel:	n/a	n/a
26	CTCF	chr2:113191180-113191330	GM12865	blood:	n/a	chr2:113191269-113191282
27	CTCF	chr2:113191180-113191363	HepG2	liver:	n/a	chr2:113191269-113191282
28	CTCF	chr2:113191240-113191390	NB4	blood:	n/a	chr2:113191269-113191282
29	CTCF	chr2:113191142-113191360	MCF-7	breast:	n/a	chr2:113191269-113191282
30	CTCF	chr2:113191177-113191349	ProgFib	skin:	n/a	chr2:113191269-113191282
31	CTCF	chr2:113191220-113191370	HUVEC	blood vessel:	n/a	chr2:113191269-113191282
32	CTCF	chr2:113191200-113191350	HAc	cerebellar:	n/a	chr2:113191269-113191282
33	CTCF	chr2:113189617-113189694	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr2:113191220-113191370	HA-sp	spinal cord:	n/a	chr2:113191269-113191282
35	CTCF	chr2:113191127-113191382	Gliobla	brain:	n/a	chr2:113191269-113191282
36	CTCF	chr2:113191127-113191372	NHEK	skin:	n/a	chr2:113191269-113191282
37	CTCF	chr2:113191240-113191390	NHLF	lung:	n/a	chr2:113191269-113191282
38	CTCF	chr2:113191116-113191588	SK-N-SH	brain:	n/a	chr2:113191269-113191282
39	CTCF	chr2:113191260-113191410	HCFaa	heart:	n/a	chr2:113191269-113191282
40	CTCF	chr2:113191220-113191370	HepG2	liver:	n/a	chr2:113191269-113191282
41	CTCF	chr2:113191220-113191370	GM12875	blood:	n/a	chr2:113191269-113191282
42	CTCF	chr2:113189620-113189770	AG10803	skin:	n/a	n/a
43	CTCF	chr2:113189520-113189670	HMF	breast:	n/a	n/a
44	CTCF	chr2:113189500-113189650	HCM	heart:	n/a	n/a
45	CTCF	chr2:113191200-113191350	HEK293	kidney:	n/a	chr2:113191269-113191282
46	CTCF	chr2:113191220-113191370	AG04450	lung:	n/a	chr2:113191269-113191282
47	CTCF	chr2:113190929-113191512	A549	lung:	n/a	chr2:113191269-113191282
48	CTCF	chr2:113190413-113190514	Spleen_OC	spleen:	n/a	n/a
49	CTCF	chr2:113191260-113191410	GM12874	blood:	n/a	chr2:113191269-113191282
50	CTCF	chr2:113191220-113191370	HVMF	connective:	n/a	chr2:113191269-113191282

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:113191234-113191284	NHDF-neo	bronchial:	n/a
2	chr2:113191194-113191244	Jurkat	blood:	n/a
3	chr2:113190197-113190247	SK-N-MC	brain:	n/a
4	chr2:113190197-113190247	HUVEC	blood vessel:	n/a
5	chr2:113191202-113191252	HRCEpiC	kidney:	n/a
6	chr2:113190197-113190247	AG09319	gingival:	n/a
7	chr2:113191234-113191284	T-47D	breast:	n/a
8	chr2:113190072-113190122	HCT-116	colon:	n/a
9	chr2:113191815-113191865	BE2_C	brain:	n/a
10	chr2:113191234-113191284	ovcar-3	ovarian:	n/a
11	chr2:113190072-113190122	AG09309	skin:	n/a
12	chr2:113191815-113191865	H1-hESC	embryonic stem cell:	embryo
13	chr2:113191815-113191865	NB4	blood:	n/a
14	chr2:113190197-113190247	GM12892	blood:	n/a
15	chr2:113190197-113190247	ECC-1	luminal epithelium:	n/a
16	chr2:113191815-113191865	PFSK-1	brain:	n/a
17	chr2:113191202-113191252	PANC-1	pancreas:	n/a
18	chr2:113191234-113191284	AG10803	skin:	n/a
19	chr2:113190072-113190122	GM06990	blood:	n/a
20	chr2:113191194-113191244	NT2-D1	testis:	n/a
21	chr2:113190197-113190247	AG10803	skin:	n/a
22	chr2:113191202-113191252	HCPEpiC	choroid plexus:	n/a
23	chr2:113191202-113191252	HRPEpiC	eye:	n/a
24	chr2:113191194-113191244	SAEC	small airway:	n/a
25	chr2:113191815-113191865	GM12892	blood:	n/a
26	chr2:113191202-113191252	NB4	blood:	n/a
27	chr2:113191234-113191284	HIPEpiC	eye:	n/a
28	chr2:113190197-113190247	HepG2	liver:	n/a
29	chr2:113191194-113191244	RPTEC	kidney:	n/a
30	chr2:113191202-113191252	AG04450	lung:	fetal
31	chr2:113191234-113191284	LNCaP	prostate:	n/a
32	chr2:113191202-113191252	K562	blood:	n/a
33	chr2:113190197-113190247	Jurkat	blood:	n/a
34	chr2:113191234-113191284	GM06990	blood:	n/a
35	chr2:113190072-113190122	BE2_C	brain:	n/a
36	chr2:113191234-113191284	AG04449	skin:	fetal
37	chr2:113190072-113190122	K562	blood:	n/a
38	chr2:113191202-113191252	HL-60	blood:	n/a
39	chr2:113191194-113191244	HIPEpiC	eye:	n/a
40	chr2:113191234-113191284	SAEC	small airway:	n/a
41	chr2:113190197-113190247	HCM	heart:	n/a
42	chr2:113191815-113191865	T-47D	breast:	n/a
43	chr2:113191234-113191284	NB4	blood:	n/a
44	chr2:113191194-113191244	ProgFib	skin:	n/a
45	chr2:113190197-113190247	HMEC	breast:	n/a
46	chr2:113191202-113191252	SAEC	small airway:	n/a
47	chr2:113191234-113191284	HRCEpiC	kidney:	n/a
48	chr2:113191202-113191252	AG10803	skin:	n/a
49	chr2:113190197-113190247	HCT-116	colon:	n/a
50	chr2:113190072-113190122	HIPEpiC	eye:	n/a

Variant related genes	Relation type
RGPD8	TF binding region
RGPD8	CpG island

Extended variants
information (count: 111 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:111 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568006932	chr2:113189313-113189314	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs13408170	chr2:113189333-113189334	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
3	rs556831009	chr2:113189358-113189359	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs180887403	chr2:113189400-113189401	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs545543091	chr2:113189406-113189407	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs563635926	chr2:113189417-113189418	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs185207836	chr2:113189461-113189462	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs573000581	chr2:113189564-113189565	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs541841787	chr2:113189623-113189624	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs561678770	chr2:113189661-113189662	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs529631279	chr2:113189681-113189682	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs531067326	chr2:113189720-113189721	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs190020143	chr2:113189755-113189756	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs182697378	chr2:113189764-113189765	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs533555483	chr2:113189778-113189779	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs185824973	chr2:113189836-113189837	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs376027442	chr2:113189847-113189848	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs386649230	chr2:113189854-113189855	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs374459037	chr2:113189877-113189878	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs566622934	chr2:113189890-113189891	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs577892118	chr2:113189911-113189912	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs191919697	chr2:113189933-113189934	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs34663792	chr2:113189949-113189950	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs569237443	chr2:113189959-113189960	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs566305437	chr2:113189987-113189988	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs550866807	chr2:113189993-113189994	Active TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs570686702	chr2:113190006-113190007	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs539618720	chr2:113190008-113190009	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs553248918	chr2:113190055-113190056	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs535215376	chr2:113190066-113190067	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs2458945	chr2:113190070-113190071	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs2458944	chr2:113190091-113190092	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs189146725	chr2:113190107-113190108	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs575214114	chr2:113190147-113190148	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs13422242	chr2:113190211-113190212	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs2458943	chr2:113190222-113190223	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs192199932	chr2:113190227-113190228	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs540419218	chr2:113190239-113190240	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs560324361	chr2:113190243-113190244	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs529299595	chr2:113190274-113190275	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs549087171	chr2:113190314-113190315	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs182250808	chr2:113190319-113190320	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs562705457	chr2:113190333-113190334	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs570529607	chr2:113190366-113190367	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs28667412	chr2:113190372-113190373	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs551512893	chr2:113190395-113190396	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs570721888	chr2:113190396-113190397	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs539782764	chr2:113190414-113190415	Active TSS Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs371589542	chr2:113190453-113190454	Active TSS Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs186909291	chr2:113190474-113190475	Active TSS Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Ocular motor apraxia	21572526	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Idiopathic chronic pancreatitis	21549014	CNVD
Mental retardation	21549014	CNVD
Maculopathy	20981449	CNVD
Nephronophthisis	22470819	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:239 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:113184400-113189600	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr2:113188000-113189600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
3	chr2:113188800-113189400	Enhancers	Primary T helper cells PMA-I stimulated	--
4	chr2:113188800-113189800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
5	chr2:113188800-113190000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
6	chr2:113188800-113190000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
7	chr2:113188800-113190000	Enhancers	Primary T helper cells fromperipheralblood	blood
8	chr2:113189000-113189400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr2:113189000-113189400	Flanking Active TSS	Adipose Nuclei	Adipose
10	chr2:113189000-113189400	Enhancers	Rectal Mucosa Donor 29	rectum
11	chr2:113189000-113189400	Enhancers	Stomach Mucosa	stomach
12	chr2:113189000-113189400	Enhancers	Hela-S3	cervix
13	chr2:113189000-113189400	Enhancers	HMEC	breast
14	chr2:113189000-113189400	Active TSS	HUVEC	blood vessel
15	chr2:113189000-113189600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr2:113189000-113189600	Enhancers	Skeletal Muscle Male	skeletal muscle
17	chr2:113189000-113189600	Enhancers	HepG2	liver
18	chr2:113189000-113189800	Enhancers	Primary T killer memory cells from peripheral blood	blood
19	chr2:113189000-113189800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr2:113189000-113190000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
21	chr2:113189000-113190400	Active TSS	Brain Angular Gyrus	brain
22	chr2:113189000-113191200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr2:113189000-113191200	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr2:113189000-113191200	Active TSS	Liver	Liver
25	chr2:113189200-113189400	Enhancers	Pancreas	Pancrea
26	chr2:113189200-113189600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr2:113189200-113189600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
28	chr2:113189200-113189600	Weak transcription	Brain Cingulate Gyrus	brain
29	chr2:113189200-113189600	Enhancers	Brain Hippocampus Middle	brain
30	chr2:113189200-113189600	Enhancers	Brain Inferior Temporal Lobe	brain
31	chr2:113189200-113189600	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
32	chr2:113189200-113189600	Enhancers	HSMMtube	muscle
33	chr2:113189200-113189600	Weak transcription	NHEK	skin
34	chr2:113189200-113190000	Enhancers	Primary T cells fromperipheralblood	blood
35	chr2:113189200-113190200	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr2:113189200-113191200	Active TSS	Osteobl	bone
37	chr2:113189400-113189600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr2:113189400-113189600	Active TSS	Adipose Nuclei	Adipose
39	chr2:113189400-113189600	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
40	chr2:113189400-113189600	Flanking Active TSS	HUVEC	blood vessel
41	chr2:113189400-113189600	Enhancers	Monocytes-CD14+_RO01746	blood
42	chr2:113189400-113189800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
43	chr2:113189400-113189800	Enhancers	Fetal Brain Female	brain
44	chr2:113189400-113190600	Enhancers	Primary B cells from cord blood	blood
45	chr2:113189400-113191200	Active TSS	Breast Myoepithelial Primary Cells	Breast
46	chr2:113189400-113191200	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr2:113189400-113191200	Active TSS	Colonic Mucosa	Colon
48	chr2:113189400-113191200	Active TSS	Hela-S3	cervix
49	chr2:113189400-113191200	Active TSS	HSMM	muscle
50	chr2:113189400-113191400	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links